From Testing to Distribution: The Logistics Behind COVID-19 Vaccines

From Testing to Distribution: The Logistics Behind COVID-19 Vaccines

Scientists work at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory.

wbur/November 18, 2020